{"id":"7599f69d-aef4-55e1-aef6-5c63be9d6254","stable_key":"e37461ea-ea5d-5e2c-8091-138305f6dd70:l-aspartate-ass1-citrin-difference","predicate":"changes_aspartate_partitioning","statement":"ASS1-deficient citrullinemia type I models showed greater pyrimidine synthesis and proliferation than citrin-deficient type II models, where aspartate delivery was restricted.","claim_class":"mechanistic","status":"source_derived_draft","evidence_grade":"ungraded","direction":"context_dependent","is_public":true,"mechanism_event_id":"c51ce7b1-8470-592b-b5ce-b6ae65a54ead","mechanism_event_label":"Two defects affecting the same cycle can leave very different amounts of substrate for another pathway.","subject":{"id":"016fece1-b5fb-5e4e-b621-210e70a64fd1","slug":"human-citrullinemia-mechanistic-comparison","display_name":"Comparison of ASS1 deficiency and citrin deficiency","entity_type_key":"cellular_process"},"object":{"id":"3f3415eb-f4e5-5667-9ce6-9fedf0bf31ad","slug":"human-citrullinemia-pyrimidine-synthesis","display_name":"Pyrimidine synthesis in citrullinemia study models","entity_type_key":"cellular_process"},"evidence_count":1,"mechanism_event":{"id":"c51ce7b1-8470-592b-b5ce-b6ae65a54ead","stable_key":"e37461ea-ea5d-5e2c-8091-138305f6dd70:l-aspartate-ass1-citrin-difference-event","event_type":"observed_relationship","label":"Two defects affecting the same cycle can leave very different amounts of substrate for another pathway.","description":"ASS1-deficient citrullinemia type I models showed greater pyrimidine synthesis and proliferation than citrin-deficient type II models, where aspartate delivery was restricted.","status":"provisional","compartment":null,"participants":[{"entity":{"id":"016fece1-b5fb-5e4e-b621-210e70a64fd1","slug":"human-citrullinemia-mechanistic-comparison","display_name":"Comparison of ASS1 deficiency and citrin deficiency","entity_type_key":"cellular_process"},"role":"subject","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"3f3415eb-f4e5-5667-9ce6-9fedf0bf31ad","slug":"human-citrullinemia-pyrimidine-synthesis","display_name":"Pyrimidine synthesis in citrullinemia study models","entity_type_key":"cellular_process"},"role":"target","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""},{"entity":{"id":"0a0923d3-72b7-5d6a-bf3a-5a7a3071a09b","slug":"l-aspartate","display_name":"L-Aspartate","entity_type_key":"small_molecule"},"role":"context_participant","stoichiometry":null,"state_label":"","sequence_order":2,"notes":""},{"entity":{"id":"d46fbb06-9880-57cf-a7eb-1238648cdbb4","slug":"ass1","display_name":"Human argininosuccinate synthetase 1 / ASS1","entity_type_key":"protein"},"role":"context_participant","stoichiometry":null,"state_label":"","sequence_order":3,"notes":""},{"entity":{"id":"5252ba8d-8e58-5fa5-abdb-7bc97ef85818","slug":"slc25a13","display_name":"Human citrin / SLC25A13","entity_type_key":"protein"},"role":"context_participant","stoichiometry":null,"state_label":"","sequence_order":4,"notes":""},{"entity":{"id":"64cc3b93-3e99-5221-bd91-049d190e54c7","slug":"cad","display_name":"Human CAD multifunctional pyrimidine synthesis enzyme","entity_type_key":"protein"},"role":"context_participant","stoichiometry":null,"state_label":"","sequence_order":5,"notes":""}]},"contexts":[{"dimension":"availability_state","value_text":"machinery_impairment","comparator":null,"unit":null,"notes":"Imported condition classification; unverified.","entity":null},{"dimension":"evidence_access","value_text":"Primary abstract","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"Human disorder-derived observations and experimental disease/cancer comparisons.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"Neither condition is simple low dietary aspartate; do not turn cellular proliferation measures into patient cancer-risk estimates.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"nutrient_topic","value_text":"L-Aspartate collection; species, compartment, exposure, co-substrates and manipulation remain explicit.","comparator":null,"unit":null,"notes":"","entity":{"slug":"l-aspartate","display_name":"L-Aspartate","entity_type_key":"small_molecule"}},{"dimension":"plain_language","value_text":"Two defects affecting the same cycle can leave very different amounts of substrate for another pathway.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"Diversion of aspartate in ASS1-deficient tumours fosters de novo pyrimidine synthesis. · 2015 · https://pubmed.ncbi.nlm.nih.gov/26560030/ · DOI 10.1038/nature15529","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"trigger_kind","value_text":"machinery_impairment","comparator":null,"unit":null,"notes":"Imported condition classification; unverified.","entity":null}],"evidence":[{"id":"c1f701ca-cc97-55ec-8b6b-ed5fefca0643","evidence_kind":"source_excerpt","locator":"Lines 178-184","start_line":178,"end_line":184,"excerpt":"## l-aspartate-ass1-citrin-difference\nTwo defects affecting the same cycle can leave very different amounts of substrate for another pathway.\nASS1-deficient citrullinemia type I models showed greater pyrimidine synthesis and proliferation than citrin-deficient type II models, where aspartate delivery was restricted.\nModel: Human disorder-derived observations and experimental disease/cancer comparisons.\nLimitations: Neither condition is simple low dietary aspartate; do not turn cellular proliferation measures into patient cancer-risk estimates.\nEvidence access: Primary abstract\nDiversion of aspartate in ASS1-deficient tumours fosters de novo pyrimidine synthesis. · 2015 · https://pubmed.ncbi.nlm.nih.gov/26560030/ · DOI 10.1038/nature15529","model_system":"Human disorder-derived observations and experimental disease/cancer comparisons.","directness":"reported_statement","verification_status":"source_derived_draft","notes":"Original curation paraphrase; evidence access and experimental limitations specified.","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"67970dcb-34e0-5b0a-8c86-d8c3cc183444","stable_key":"import-e37461ea-ea5d-5e2c-8091-138305f6dd70","title":"L-Aspartate: redox transfer, nitrogen partitioning and cross-nutrient mechanisms (2026-09-19)","document_type":"imported_text","citation_label":"AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text.","file_path":"","sha256":"a2791036b8f554be57d0b40892634bb9c900fa03e7e4c9c95ca08428ed52d614","revision_id":"150613bb-a227-5ec9-9f5c-fb13f5da50c8","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}